人类乳头状瘤病毒33 E6蛋白抗体

Quantity size:

0.2ml

Concentration:

1mg/ml 人类乳头状瘤病毒33 E6蛋白抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Human papilloma viruses (HPVs) can be classified as either high risk or low risk according to their association with cancer. HPV16 and HPV18 are the most common of the high risk group while HPV6 and HPV11 are among the low risk types. Approximately 90% of cervical cancers contain HPV DNA of the high risk types. Mutational analysis have shown that人类乳头状瘤病毒33 E6蛋白抗体 the E6 and E7 genes of the high risk HPVs are necessary and sufficient for HPV transforming function. The specific interactions of the E6 and E7 proteins with p53 and pRB, respectively, correlate with HPV high and low risk classifications. The high risk HPV E7 proteins bind to pRB with a higher affinity than do the low risk HPV proteins, and only the high risk HPV E6 proteins form detectable complexes with p53 in vitro. 
Human papillomaviruses (HPV) are small DNA viruses which infect epithelia of the skin and mucosa人类乳头状瘤病毒33 E6蛋白抗体. Over 90 types have been identified and they mostly cause a variety of benign lesions such as warts and verrucae. However, some subtypes, notably types 16 and 18, 31 and 33, have been confirmed as agents which cause cervical cancer.

Also known as:

E6 protein [Human papillomavirus type 33]; Human Papilloma Virus; Human papillomavirus type 33;人类乳头状瘤病毒33 E6蛋白抗体 Human papillomavirus type 33; Protein 33; HPV33-E6 protein; HPV33 E6 protein; VE6_HPV33.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: HPV33.

●

Immunogen: KLH conjugated synthetic peptide derived from human HPV33 E6.

●

人类乳头状瘤病毒33 E6蛋白抗体Predicted Molecular Weight: 16kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl003Mu01载脂蛋白B(APOB)多克隆抗体Polyclonal Antibody to Apolipoprotein B (APOB)

kl003Ra01载脂蛋白B(APOB)多克隆抗体Polyclonal Antibody to Apolipoprotein B (APOB)

kl704Hu01载脂蛋白E(APOE)多克隆抗体Polyclonal Antibody to Apolipoprotein E (APOE)

kl704Mu01载脂蛋白E(APOE)多克隆抗体Polyclonal Antibody to Apolipoprotein E (APOE)

kl704Ra01载脂蛋白E(APOE)多克隆抗体Polyclonal Antibody to Apolipoprotein E (APOE)

kl519Hu01载脂蛋白A1(APOA1)多克隆抗体Polyclonal Antibody to Apolipoprotein A1 (APOA1)

kl519Mu01载脂蛋白A1(APOA1)多克隆抗体Polyclonal Antibody to Apolipoprotein A1 (APOA1)

kl519Ra01载脂蛋白A1(APOA1)多克隆抗体Polyclonal Antibody to Apolipoprotein A1 (APOA1)

kl033Hu01干扰素α(IFNα)多克隆抗体Polyclonal Antibody to Interferon Alpha (IFNa)

kl033Ra01干扰素α(IFNα)多克隆抗体Polyclonal Antibody to Interferon Alpha (IFNa)

kl578Hu01Pim-1原癌基因(PIM1)多克隆抗体Polyclonal Antibody to Pim-1 Oncogene (PIM1)

kl578Mu01Pim-1原癌基因(PIM1)多克隆抗体Polyclonal Antibody to Pim-1 Oncogene (PIM1)

kl578Ra01Pim-1原癌基因(PIM1)多克隆抗体Polyclonal Antibody to Pim-1 Oncogene (PIM1)

kl305Hu01甲状腺结合球蛋白(TBG)多克隆抗体Polyclonal Antibody to Thyroxine Binding Globulin (TBG)

kl305Mu01甲状腺结合球蛋白(TBG)多克隆抗体Polyclonal Antibody to Thyroxine Binding Globulin (TBG)

kl305Ra01甲状腺结合球蛋白(TBG)多克隆抗体Polyclonal Antibody to Thyroxine Binding Globulin (TBG)

kl702Hu01硫氧化还原蛋白(Trx)多克隆抗体Polyclonal Antibody to Thioredoxin (Trx)

kl702Mu01硫氧化还原蛋白(Trx)多克隆抗体Polyclonal Antibody to Thioredoxin (Trx)

kl702Ra01硫氧化还原蛋白(Trx)多克隆抗体Polyclonal Antibody to Thioredoxin (Trx)

kl084Mu01瘦素(LEP)多克隆抗体Polyclonal Antibody to Leptin (LEP)

kl084Ra01瘦素(LEP)多克隆抗体Polyclonal Antibody to Leptin (LEP)

kl036Hu01转铁蛋白(TRF)多克隆抗体Polyclonal Antibody to Transferrin (TRF)

kl036Mu01转铁蛋白(TRF)多克隆抗体Polyclonal Antibody to Transferrin (TRF)